FDA Adverse Event Injury Summary report: N

NIRA PRO

MDR report key: 22208421 · Received June 14, 2025

Report

Report Number
3015109022-2025-00001
Event Type
Injury
Date Received
June 14, 2025
Date of Event
May 15, 2024
Report Date
October 29, 2024
Manufacturer
NIRA INNOVATIONS INC
Product Code
OHS
UDI-DI
00850020752119
PMA / PMN Number
K222685
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

ON (B)(6) 2024, PATIENT, A 76-YEAR-OLD WOMAN, EXPERIENCED A SEVERE ADVERSE REACTION UPON WAKING UP THAT DAY. SHE WOKE UP TO FIND HER FACE SIGNIFICANTLY DISTORTED, WITH LUMPS, DARK AREAS, AND SWELLING. THE INTERNAL INFLAMMATION WAS SO SEVERE THAT IT MADE FLOSSING HER TEETH DIFFICULT DUE TO THE SWELLING INSIDE HER MOUTH. SHE HAD BEEN USING THE NIRA PRO DEVICE INTERMITTENTLY FOR THREE MONTHS. DESPITE HER CAREFUL USE, SHE DID NOT NOTICE ANY CHANGES UNTIL THE MORNING OF (B)(6) 2024, WHEN THE ADVERSE SYMPTOMS APPEARED SUDDENLY. SHE CLAIMS THAT THIS INFLAMMATION MAY BE THE RESULT OF THE NIRA LASER USE, HOWEVER THERE WAS NO DIRECT CONNECTION BETWEEN USING THE LASER FOR MANY MONTHS AND THIS PARTICULAR OVERNIGHT REACTION. IN AN ATTEMPT TO ADDRESS THE ISSUE, SHE VISITED HER DERMATOLOGIST, DR. (B)(6), ON (B)(6) 2024. DUE TO HER MEDICAL HISTORY, WHICH INCLUDES A PREVIOUS PERFORATED ULCER THAT PREVENTS HER FROM TAKING ANTI-INFLAMMATORIES, SHE WAS PRESCRIBED DOXYCYCLINE (100 MG, TWICE A DAY) AND OPZELURA CREAM. THE TREATMENT HAS LED TO SOME IMPROVEMENT, BUT AS OF (B)(6) 2024, SHE STILL EXPERIENCES SOME SWELLING AND BULGES ON HER FACE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
635991 NIRA PRO NIRA PRO OHS NIRA INNOVATIONS INC 151-001 022920241 00850020752119

Patients

Seq Age Sex Outcome Treatment
1 76 YR Female Other BLOOD PRESSURE MEDICATION.| CHOLESTEROL MEDICATION.| DAILY VITAMINS.| ESTROGEN.| THYROID MEDICATION.| TYLENOL EXTRA STRENGTH.